329
Views
43
CrossRef citations to date
0
Altmetric
Original

In vitro intestinal transport and antihypertensive activity of ACE inhibitory pea and whey digests

, , , , &
Pages 415-430 | Published online: 06 Jul 2009

References

  • Abubakar A, Saito T, Kitazawa H, Kawai Y, Itoh T. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J Dairy Sci 1998; 81: 3131–3138
  • Augustijns P, Annaert P, Heylen P, Van den Mooter G, Kinget R. Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport. Int J Pharm 1998; 166: 45–53
  • Boisset M, Botham RP, Haegele KD, Lenfant B, Pachot JI. Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: Importance of drug ionisation in the in vitro prediction of in vivo absorption. Eur J Pharm Sci 2000; 10: 215–224
  • Burton PS, Conradi RA, Ho NFH, Hilgers AR, Borchardt RT. How structural features influence the biomembrane permeability of peptides. J Pharm Sci 1996; 85: 1336–1340
  • Chao AC, Nguyen JV, Broughall M, Griffin A, Fix JA, Daddona PE. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int J Pharm 1999; 191: 15–24
  • Daniel H, Herget M. Intestinal and renal transport of peptides at the cellular and molecular level. Peptides in mammalian protein metabolism. Tissue utilization and clinical targeting, GK Grimble, FRC Backwell. Portland Press Ltd, LondonUK 1998
  • Dziuba J, Minkiewicz P, Nalecz D. Biologically active peptides from plant and animal proteins. Pol J Food Nutr Sci 1999; 8: 3–16
  • Eriksson U, Danilczyk U, Penninger JM. Just the beginning: novel functions for angiotensin-converting enzymes. Curr Biol 2002; 12: R745–R752
  • Fitzgerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Brit J Nutr 2000; 84: S33–S37
  • French JF, Anderson BA, Downs TR, Dage RC. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension. J Cardiovasc Pharmacol 1995; 26: 107–113
  • Fuglsang A, Nilsson D, Nyborg NCB. Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats. Appl Environ Microbiol 2002; 68: 3566–3569
  • Fujita H, Usui H, Kurahashi K, Yoshikawa M. Isolation and characterization of Ovokinin, a Bradykinin B-1 Agonist peptide derived from Ovalbumin. Peptides 1995; 16: 785–790
  • Gardner MLG. Transmucosal passage of intact peptides. Peptides in mammalian metabolism. Tissue utilization and clinical targeting, GK Grimble, FRC Backwell. Portland Press Ltd, LondonUK 1998
  • Hashimoto K, Matsunaga N, Shimizu M. Effect of vegetable extracts on the transepithelial permeability of the human intestinal Caco-2 cell monolayer. Biosci Biotechnol Biochem 1994; 58: 1345–1346
  • Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64: 767–771
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
  • Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 1996; 126: 3063–3068
  • Matoba N, Usui H, Fujita H, Yoshikawa M. A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett 1999; 452: 181–184
  • Matsufuji H, Matsui T, Ohshige S, Kawasaki T, Osajima K, Osajima Y. Antihypertensive effects of angiotensin fragments in SHR. Biosci Biotechnol Biochem 1995; 59: 1398–1401
  • Matsui T, Li CH, Tanaka T, Maki T, Osajima Y, Matsumoto K. Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biol Pharm Bull 2000; 23: 427–431
  • Matsui T, Tamaya K, Seki E, Osajima K, Matsumoto K, Kawasaki T. Absorption of Val-Tyr with in vitro angiotensin I-converting enzyme inhibitory activity into the circulating blood system of mild hypertensive subjects. Biol Pharm Bull 2002a; 25: 1228–1230
  • Matsui T, Tamaya K, Seki E, Osajima K, Matsumoto K, Kawasaki T. Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system. Clin Exp Pharmacol Physiol 2002b; 29: 204–208
  • Moskowitz DW. Is ‘somatic’ angiotensin-I-converting enzyme a mechanosensor?. Diabetes Technol Therap 2003; 4: 841–858
  • Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol 2000; 279: G851–G857
  • Pappenheimer JR, Karnovsky ML, Maggio JE. Absorption and excretion of undegradable peptides: Role of lipid solubility and net charge. J Pharmacol Exp Therap 1997; 280: 292–300
  • Pihlanto-Leppälä A. Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptides. Trends Food Sci Technol 2001; 11: 347–356
  • Rubio LA, Seiquer I. Transport of amino acids from in vitro digested legume proteins or casein in Caco-2 cell cultures. J Agric Food Chem 2002; 50: 5202–5206
  • Satake M, Enjoh M, Nakamura Y, Takano T, Kawamura Y, Arai S, Shimizu M. Transepithelial transport of the bioactive tripeptide, Val-Pro- Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 2002; 66: 378–384
  • Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American J Clin Nutr 2003; 77: 326–330
  • Shimizu M. Modulation of intestinal functions by food substances. Nahrung-Food 1999; 43: 154–158
  • Shimizu M, Tsunogai M, Arai S. Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 1997; 18: 681–687
  • Shin ZI, Yu R, Park SA, Chung DK, Ahn CW, Nam HS, Kim KS, Lee HJ. His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo. J Agric Food Chem 2001; 49: 3004–3009
  • Sipola M, Finckenberg P, Korpela R, Vapaatalo H, Nurminen ML. Effect of long-term intake of milk products on blood pressure in hypertensive rats. J Dairy Res 2002; 69: 103–111
  • Takano T. Milk derived peptides and hypertension reduction. Int Dairy J 1998; 8: 375–381
  • Vermeirssen V, Van Camp J, Decroos K, Van Wijmelbeke L, Verstraete W. The impact of fermentation and in vitro digestion on the formation of ACE inhibitory activity from pea and whey protein. J Dairy Sci 2003a; 86: 429–438
  • Vermeirssen V, Van Camp J, Devos L, Verstraete W. Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: from batch experiment to semi-continuous model. J Agric Food Chem 2003b; 51: 5680–5687
  • Vermeirssen V, Van Camp J, Verstraete W. Optimisation and validation of an Angiotensin Converting Enzyme (ACE) inhibition assay for the screening of bioactive peptides. J Biochem Biophys Methods 2002; 51: 75–87
  • Vermeirssen V, Van Camp J, Verstraete W. Fractionation of angiotensin I converting enzyme inhibitory activity from pea and whey protein in vitro gastrointestinal digests. J Sci Food Agric 2005; 85: 399–405
  • Walker D, Thwaites DT, Simmons NL, Gilbert HJ, Hirst BH. Substrate upregulation of the human small intestinal peptide transporter, hPepT1. J Physiol-London 1998; 507: 697–706
  • Wilson G, Hassan IF, Dix CJ, Williamson I, Shah R, Mackay M, Artursson P. Transport and permeability properties of human Caco-2 cells-An in vitro model of the intestinal epithelial-cell barrier. J Controlled Release 1990; 11: 25–40
  • Winckler C, Breves G, Boll M, Daniel H. Characteristics of dipeptide transport in pig jejunum in vitro. J Comp Physiol B-Biochem Systemic Environ Physiol 1999; 169: 495–500
  • Wu JP, Ding XL. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J Agric Food Chem 2001; 49: 501–506
  • Yamamoto N. Antihypertensive peptides derived from food proteins. Biopolymers 1997; 43: 129–134
  • Yang CY, Dantzig AH, Pidgeon C. Intestinal peptide transport systems and oral drug availability. Pharm Res 1999; 16: 1331–1343
  • Yoshii H, Tachi N, Ohba R, Sakamura O, Takeyama H, Itani T. Antihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks. Comp Biochem Physiol C-Toxicol Pharmacol 2001; 128: 27–33
  • Yoshioka M, Erickson R, Woodley J, Gulli R, Guan D, Kim YS. Role of rat intestinal brush-border membrane angiotensin-converting enzyme in dietary protein digestion. Am J Physiol 1987; 253: G781–G786

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.